---
title: The gut microbiome is associated with disease-free survival in stage I-III
  colorectal cancer patients
date: '2025-01-31'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39887373/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250131170637&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Colorectal cancer (CRC) is the second overall leading cause of cancer
  death in the United States, with recurrence being a frequent cause of mortality.
  Approaches to improve disease-free survival (DFS) are urgently needed. The gut microbiome,
  reflected in fecal samples, is likely mechanistically linked to CRC progression
  and may serve as a non-invasive biomarker. Accordingly, we leveraged baseline fecal
  samples from N = 166 stage I-III CRC patients in the ColoCare Study, a prospective
  cohort ...
disable_comments: true
---
Colorectal cancer (CRC) is the second overall leading cause of cancer death in the United States, with recurrence being a frequent cause of mortality. Approaches to improve disease-free survival (DFS) are urgently needed. The gut microbiome, reflected in fecal samples, is likely mechanistically linked to CRC progression and may serve as a non-invasive biomarker. Accordingly, we leveraged baseline fecal samples from N = 166 stage I-III CRC patients in the ColoCare Study, a prospective cohort ...